greeksoup/ stock research

Merck (MRK) FY2021 results: revenue $48.7 billion, up 17.3% on the year

Merck & Co., Inc. (MRK) reported revenue of $48.7 billion for fiscal 2021, the year ended 31 December 2021, up 17.3% on the year before. Net income was $13.0 billion, up 84.6%, and diluted earnings per share $5.14. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2022.

Revenue
$48.7 billion
+17.3% on the year
FY2014FY2021
Operating margin
n/a
FY2014FY2021
Net income
$13.0 billion
+84.6% on the year
FY2014FY2021
Diluted EPS
$5.14
+84.9% on the year
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue48,70441,51839,121+17.3%
Cost of revenue13,62613,61812,016+0.1%
Gross profit35,07827,90027,105+25.7%
Gross margin72.0%67.2%69.3%
Research and development12,24513,3979,724-8.6%
Selling, general and administrative9,6348,9559,455+7.6%
Interest expense806831893-3.0%
Pre-tax income13,8795,8637,171+136.7%
Income tax1,5211,3401,565+13.5%
Effective tax rate11.0%22.9%21.8%
Net income13,0497,0679,843+84.6%
Net margin26.8%17.0%25.2%
Diluted EPS$5.14$2.78$3.81+84.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow14,10910,25313,440+37.6%
Capital expenditure4,4484,4293,369+0.4%
Free cash flow9,6615,82410,071+65.9%
Free cash flow margin19.8%14.0%25.7%
Cash from investingn/a-9,443-2,629
Cash from financingn/a-2,832-8,861
Depreciation and amortisation3,1783,4693,652-8.4%
Share-based compensation479441388+8.6%
Buybacks8401,2814,780-34.4%
Dividends paid6,6106,2155,695+6.4%
Dividend per share$2.64$2.48$2.26+6.5%
Diluted shares, weighted2,538m2,541m2,580m-0.1%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity38,18425,31725,907+50.8%
Non-controlling interest73.087.094.0-16.1%
Debt33,10031,80026,300+4.1%
Operating lease liabilities1,2251,335768-8.2%
Other liabilities33,11233,04931,328+0.2%
Total liabilities and equity105,69491,58884,397+15.4%
Fixed assets19,27917,00014,297+13.4%
Goodwill21,26418,88218,069+12.6%
Intangible assets22,93314,10114,196+62.6%
Investments3707852,243-52.9%
Cash and equivalents8,0968,0629,676+0.4%
Receivables9,2306,8036,778+35.7%
Inventory5,9535,5545,978+7.2%
Other assets18,56920,40113,160-9.0%
Total assets105,69491,58884,397+15.4%

10-K for the year ended 31 December 2021, filed 25 February 2022: the filing.